Alternatywne metody leczenia atopowego zapalenia skóry u psów

Piśmiennictwo

Bachmann M.F., Zeltins A., Kalnins G., Balke I., Fischer N., Rostaher A., Favrot C.: Vaccination against IL-31 for the treatment of atopic dermatitis in dogs. „Journal of Allergy and Clinical Immunology”, 2018, 142 (1), 279-281.

Bahamondes F., Flores E., Cattaneo G., Bruna F., Conget P.: Omental adipose tissue is a more suitable source of canine Mesenchymal stem cells. „BMC Vet Res”, 2017, 13, 166.

Black L., Zacharias S., Hughes M., Bautista R., Taechangam N., Sand T.: The effect of uterine-derived mesenchymal stromal cells for the treatment of canine atopic dermatitis: A pilot study. „Frontiers in Veterinary Science”, 2022, 9. DOI: 10.3389/fvets.2022.1011174.

Cadot P., Hensel P., Bensignor E., Hadjaje C., Marignac G., Beco L., Fontaine J., Jamet J.F., Georgescu G., Campbell K., Cannon A., Osborn S.C., Messinger L., Gogny-Goubert M., Dubreuil P., Moussy A., Hermine O.: Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial. „Vet Dermatol”, 2011, 22 (6), 554-64.

Campora L., Miragliotta V., Ricci E., Cristino L., Di Marzo V., Albanese F., Federica Della Valle M., Abramo F.: Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis. „Am J Vet Res”, 2012, 73 (7), 988-95.

Carlotti D.N., Boulet M., Ducret J., Machicote G., Jasmin P., Rème C.A., Albouy M.: The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study. „Veterinary Dermatology”, 2009, 20 (5-6), 405-411.

Daigle J., Moussy A., Mansfield C.D., Hermine O.: Masitinib for the treatment of canine atopic dermatitis: a pilot study. „Veterinary Research Communications”, 2010, 34 (1), 51-63.

de Oliveira Ramos F., Malard P.F., Brunel H.D.S.S., Paludo G.R., de Castro M.B., da Silva P.H.S., da Cunha  Barreto-Vianna A.R.: Canine atopic dermatitis attenuated by mesenchymal stem cells. „J Adv Vet Anim Res”, 2020, 7 ...